Visualitza VHIO - Articles científics per autor "Han, Ji-Youn"
Ara mostrant els elements 1-2 d 2
-
Brigatinib Versus Crizotinib in ALK Inhibitor–Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial
Camidge, D. Ross; Ahn, Myung-Ju; Yang, James C. H.; Han, Ji-Youn; Hochmair, Maximilian J.; Felip Font, Enriqueta; Kim, Hye Ryun (Elsevier, 2021-12-01) -
Olmutinib in T790M-positive non–small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study
Park, Keunchil; Jӓnne, Pasi A.; Kim, Dong-Wan; Han, Ji-Youn; Wu, Ming-Fang; Lee, Jong-Seok; Felip Font, Enriqueta (Wiley, 2021-05-01)